MedPath

The effects of Filgrastimin on Complications of patients with cerebral hemorrhage ?due to head trauma ?

Phase 2
Conditions
cerebral hemorrhage ?due to head trauma.
Intracerebral haemorrhage in hemisphere, cortical
Registration Number
IRCT2017020120258N30
Lead Sponsor
Vice chancellor for research, Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
68
Inclusion Criteria

18 years and more; patients with cerebral hemorrhage due to head trauma; level of consciousness between 9 -13
Exclusion criteria: alcohol consumption and addiction; allergy for drug; history of hypertension and diabetes and embolism and deep vein thrombosis; patient died 72 hours after admission

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood pressure. Timepoint: Before and in and after treatment. Method of measurement: Barometer.;Hemoglobin. Timepoint: Before and in and after treatment. Method of measurement: Blood test.;Electrolytes. Timepoint: Before and in and after treatment. Method of measurement: Blood test.;Hematocrit. Timepoint: Before and in and after treatment. Method of measurement: Blood test.;Paralyzed limb strength ?. Timepoint: before and after treatment. Method of measurement: Physical examination.;Deep vein thrombosis. Timepoint: before and after treatment. Method of measurement: CT venography.;Number of hospitalization days ?. Timepoint: After treatment. Method of measurement: Observation.;Mortality. Timepoint: After treatment. Method of measurement: Observation.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath